1. Home/
  2. Compounds/
  3. carboplatin:etoposide (40:17 mol/mol)

carboplatin:etoposide (40:17 mol/mol)

Synonyms

SourcesNames Used
CTRPv2carboplatin:etoposide (40:17 mol/mol)
PharmacoGx carboplatin:etoposide (40:17 mol/mol)

Cell lines tested with carboplatin:etoposide (40:17 mol/mol)

829 cell lines have been tested with this compound, using data from 1 dataset(s).
CAS-1 central nervous system CTRPv21
KPL-1 breast CTRPv21
MKN1 stomach CTRPv21
253J-BV urinary tract CTRPv21
BFTC-905 urinary tract CTRPv21
BFTC-909 urinary tract CTRPv21
CAL-120 breast CTRPv21
CAL-29 urinary tract CTRPv21
CAL-62 thyroid CTRPv21
HuCCT1 biliary tract CTRPv21
Download CSV

Tissues tested with carboplatin:etoposide (40:17 mol/mol)

25 tissues have been tested with this compound, using data from 1 dataset(s).
central nervous systemCTRPv246
breastCTRPv240
stomachCTRPv232
urinary tractCTRPv225
thyroidCTRPv210
biliary tractCTRPv25
skinCTRPv245
haematopoietic and lymphoid tissueCTRPv2147
autonomic gangliaCTRPv213
liverCTRPv222
Download CSV
Download Data as CSV

Top molecular features associated with response to carboplatin:etoposide (40:17 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HNRNPA1L2 CTRPv2 AAC 0.32 7e-20
mRNA LMNB1 CTRPv2 AAC 0.28 1e-18
mRNA HNRNPA0 CTRPv2 AAC 0.27 2e-18
mRNA YPEL1 CTRPv2 AAC 0.27 4e-18
mRNA HNRNPDL CTRPv2 AAC 0.28 5e-18
mRNA HNRNPA1 CTRPv2 AAC 0.28 3e-17
mRNA SLFN11 CTRPv2 AAC 0.26 3e-17
mRNA ZNF445 CTRPv2 AAC 0.28 1e-16
mRNA ARHGAP19 CTRPv2 AAC 0.3 3e-16
mRNA CDCA7 CTRPv2 AAC 0.27 3e-16
Download CSV